Search Results - "Furgała, Anna"

Refine Results
  1. 1

    Serotonergic Neurotransmission System Modulator, Vortioxetine, and Dopaminergic D2/D3 Receptor Agonist, Ropinirole, Attenuate Fibromyalgia-Like Symptoms in Mice by Sałat, Kinga, Furgała-Wojas, Anna

    Published in Molecules (Basel, Switzerland) (20-04-2021)
    “…Fibromyalgia is a disease characterized by lowered pain threshold, mood disorders, and decreased muscular strength. It results from a complex dysfunction of…”
    Get full text
    Journal Article
  2. 2

    Interventional and preventive effects of aripiprazole and ceftriaxone used alone or in combination on oxaliplatin-induced tactile and cold allodynia in mice by Sałat, Kinga, Furgała, Anna, Sałat, Robert

    Published in Biomedicine & pharmacotherapy (01-03-2019)
    “…[Display omitted] •In mice aripiprazole and ceftriaxone attenuate oxaliplatin-induced tactile allodynia.•These drugs do not reduce cold allodynia caused by…”
    Get full text
    Journal Article
  3. 3

    The Microglial Activation Inhibitor Minocycline, Used Alone and in Combination with Duloxetine, Attenuates Pain Caused by Oxaliplatin in Mice by Sałat, Kinga, Furgała-Wojas, Anna, Sałat, Robert

    Published in Molecules (Basel, Switzerland) (11-06-2021)
    “…The antitumor drug, oxaliplatin, induces neuropathic pain, which is resistant to available analgesics, and novel mechanism-based therapies are being evaluated…”
    Get full text
    Journal Article
  4. 4

    Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT1A receptor selective agonist, NLX-112 in mouse models of pain by Sałat, Kinga, Kołaczkowski, Marcin, Furgała, Anna, Rojek, Adriana, Śniecikowska, Joanna, Varney, Mark A., Newman-Tancredi, Adrian

    Published in Neuropharmacology (01-10-2017)
    “…NLX-112 (a.k.a. befiradol, F13640) is a drug candidate intended for the treatment of l-DOPA-induced dyskinesia. It is a highly selective serotonin 5-HT1A…”
    Get full text
    Journal Article
  5. 5

    Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity-In Vitro and In Vivo Studies by Latacz, Gniewomir, Sałat, Kinga, Furgała-Wojas, Anna, Martyniak, Adrian, Olejarz-Maciej, Agnieszka, Honkisz-Orzechowska, Ewelina, Szymańska, Ewa

    Published in Molecules (Basel, Switzerland) (27-01-2022)
    “…Trying to meet the multitarget-directed ligands strategy, a series of previously described aryl-substituted phenylalanine derivatives, reported as competitive…”
    Get full text
    Journal Article
  6. 6

    Time-shifted co-administration of sub-analgesic doses of ambroxol and pregabalin attenuates oxaliplatin-induced cold allodynia in mice by Furgała, Anna, Fijałkowski, Łukasz, Nowaczyk, Alicja, Sałat, Robert, Sałat, Kinga

    Published in Biomedicine & pharmacotherapy (01-10-2018)
    “…[Display omitted] •Oxaliplatin-induced cold allodynia is a pharmacoresistant painful condition.•Novel therapeutic strategies to overcome cold allodynia are…”
    Get full text
    Journal Article
  7. 7

    Wide-Range Measurement of Thermal Preference-A Novel Method for Detecting Analgesics Reducing Thermally-Evoked Pain in Mice by Sałat, Kinga, Furgała-Wojas, Anna, Awtoniuk, Michał, Sałat, Robert

    Published in Molecules (Basel, Switzerland) (25-01-2021)
    “…Wide use of oxaliplatin as an antitumor drug is limited by severe neuropathy with pharmacoresistant cold hypersensitivity as the main symptom. Novel analgesics…”
    Get full text
    Journal Article
  8. 8

    Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain by Sałat, Kinga, Furgała, Anna, Sałat, Robert

    Published in Inflammopharmacology (01-04-2018)
    “…Background Cebranopadol (a.k.a. GRT-6005) is a dually acting nociceptin/orphanin FQ and opioid receptor agonist that has been recently developed in Phase 2…”
    Get full text
    Journal Article
  9. 9

    Acute cold allodynia induced by oxaliplatin is attenuated by amitriptyline by Furgała, Anna, Sałat, Robert, Sałat, Kinga

    Published in Acta neurobiologiae experimentalis (01-01-2018)
    “…Oxaliplatin is a third-generation, platinum-based antitumor drug used to treat colorectal cancer. Since its main adverse effect is neuropathic pain resulting…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Searching for analgesic drug candidates alleviating oxaliplatin‐induced cold hypersensitivity in mice by Sałat, Kinga, Furgała, Anna, Malikowska‐Racia, Natalia

    Published in Chemical biology & drug design (01-06-2019)
    “…Oxaliplatin is a third‐generation, platinum‐based derivative used to treat advanced colorectal cancer. Within the patient population on oxaliplatin therapy, a…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Synthesis, biological evaluation and molecular docking studies of novel quinuclidinone derivatives as potential antimicrobial and anticonvulsant agents by Łączkowski, Krzysztof Z., Landowska, Katarzyna, Biernasiuk, Anna, Sałat, Kinga, Furgała, Anna, Plech, Tomasz, Malm, Anna

    Published in Medicinal chemistry research (01-09-2017)
    “…Synthesis and investigation of antimicrobial and anticonvulsant activity of eleven novel quinuclidinone-thiazole derivatives are presented. Among the…”
    Get full text
    Journal Article
  14. 14

    The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect by Pytka, Karolina, Dziubina, Anna, Młyniec, Katarzyna, Dziedziczak, Agnieszka, Żmudzka, Elżbieta, Furgała, Anna, Olczyk, Adrian, Sapa, Jacek, Filipek, Barbara

    Published in Pharmacological reports (01-04-2016)
    “…Depression is one of the most common mental disorders and social issue worldwide. Although there are many antidepressants available, the effectiveness of the…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20